Integra LifeSciences Holdings Corp. (IART)
11.91
-0.42
(-3.37%)
USD |
NASDAQ |
Oct 23, 16:00
11.90
-0.01
(-0.08%)
After-Hours: 20:00
Integra LifeSciences Holdings Market Cap : 926.35M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 926.35M |
| October 22, 2026 | 958.63M |
| October 21, 2026 | 920.90M |
| October 20, 2026 | 1.037B |
| October 19, 2026 | 1.046B |
| October 16, 2026 | 1.027B |
| October 15, 2026 | 1.052B |
| October 14, 2026 | 1.025B |
| October 13, 2026 | 1.077B |
| October 12, 2026 | 1.087B |
| October 09, 2026 | 1.045B |
| October 08, 2026 | 1.043B |
| October 07, 2026 | 1.011B |
| October 06, 2026 | 1.036B |
| October 05, 2026 | 1.034B |
| October 02, 2026 | 986.24M |
| October 01, 2026 | 1.251B |
| September 30, 2026 | 1.266B |
| September 29, 2026 | 1.294B |
| September 28, 2026 | 1.265B |
| September 25, 2026 | 1.254B |
| September 24, 2026 | 1.235B |
| September 23, 2026 | 1.208B |
| September 22, 2026 | 1.246B |
| September 21, 2026 | 1.213B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.184B |
| September 17, 2026 | 1.174B |
| September 16, 2026 | 1.249B |
| September 15, 2026 | 1.220B |
| September 14, 2026 | 1.222B |
| September 11, 2026 | 1.206B |
| September 10, 2026 | 1.209B |
| September 09, 2026 | 1.264B |
| September 08, 2026 | 1.265B |
| September 04, 2026 | 1.300B |
| September 03, 2026 | 1.279B |
| September 02, 2026 | 1.307B |
| September 01, 2026 | 1.293B |
| August 31, 2026 | 1.316B |
| August 28, 2026 | 1.314B |
| August 27, 2026 | 1.311B |
| August 26, 2026 | 1.313B |
| August 25, 2026 | 1.306B |
| August 24, 2026 | 1.298B |
| August 21, 2026 | 1.302B |
| August 20, 2026 | 1.290B |
| August 19, 2026 | 1.341B |
| August 18, 2026 | 1.365B |
| August 17, 2026 | 1.374B |
| August 14, 2026 | 1.426B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Penumbra, Inc. | 12.78B |
| Abbott Laboratories | 179.44B |
| Boston Scientific Corp. | 66.10B |
| Globus Medical, Inc. | 10.93B |
| Sight Sciences, Inc. | 491.90M |
Market Cap Related Metrics
| PE Ratio | 72.45 |
| PS Ratio | 0.56 |
| Price to Book Value | 0.8688 |
| Price to Free Cash Flow | 12.96 |
| Price | 11.91 |
| Earnings Yield | 1.38% |
| Operating PE Ratio | 4.815 |
| Normalized PE Ratio | 10.64 |